Unilateral eyelid ptosis: A case report cured by Gelsemium sempervirens

Main Article Content

Nur-E-Alam Rasel*
Md. Akther-uz-Zahan
Rumana Afroze Rume

Abstract

Background: A 60 years-old man presented with an 8-day history of acute onset painless left upper eyelid ptosis covering the pupil entirely. Ptosis can affect unilateral or bilateral. He had no other symptoms; importantly pupils were equal and reactive and eye movements were full. There was no palpable mass or swelling. He had a headache but had no other focal neurological signs or symptoms of fatigue. MRI of brain and Orbits showed no remarkable abnormality detected in brain & orbits.


Objectives: Assessment of the homeopathic symptomatic aspects of Gelsemium sempervirens on eyelid ptosis. Showed homeopathy has a major role in the treatment of ptosis. Materials and Methods. The case management was conducted for 3 weeks and only two follow follow-ups were was taken according to the law of homeopathy.


Result: Administrating Gelsemium sempervirens 30°C of 5/7 pills orally thrice a day for a week; left eyelid ptosis was improved 60%. The ptosis resolved quickly and the patient remains symptom-free 100% at 3 weeks follow-up by next high potency Gelsemium sempervirens 200C with the same pattern.


Conclusion: Acute ptosis may indicate serious pathology. A careful history and examination must be taken. The appropriate management requires recognition of the underlying cause of it. This case presentation highlights the various aspects of ptosis evaluation and management by homeopathy for future study.

Downloads

Download data is not yet available.

Article Details

Rasel, N.-E.-A., Akther-uz-Zahan, M., & Rume, R. A. (2021). Unilateral eyelid ptosis: A case report cured by Gelsemium sempervirens. Global Journal of Medical and Clinical Case Reports, 8(2), 076–080. https://doi.org/10.17352/2455-5282.000134
Short Communications

Copyright (c) 2021 Rasel NE, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.

We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.

Peertechz accomplice with- [CC BY 4.0]

Explanation

'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.

Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.

With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:

License Name

Permission to read and download

Permission to display in a repository

Permission to translate

Commercial uses of manuscript

CC BY 4.0

Yes

Yes

Yes

Yes

The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.

Văcăraș V, Nistor C, Rahovan I, Văcăraş C, Vithoulkas G (2020) Myasthenia Gravis Therapy with Individualized Homeopathy: A Case Report. Clinical Case Reports 8: 2464-2468. Link: https://bit.ly/3xkRU90

Caplan LR (1974) Ptosis. J Neurol Neurosurg Psychiatry 37: 1-7. Link: https://bit.ly/3yoyH7o

Pauly M, Sruthi R (2019) Ptosis: Evaluation and management. Kerala J Ophthalmol 31: 11-16. Link: https://bit.ly/3lqGbTV

Vithoulkas G (2012) The science of homeopathy. Athens, Greece: International Academy of Classical Homeopathy;

Vithoulkas G, Van Woensel E (2010) Levels of Health. The Second Volume of the Science of Homeopathy. Sporades, Greece: International Academy of Classical Homeopathy.

Vithoulkas G, Van Woensel E (2010) Levels of health: practical applications and cases. Athen: International Academy of Classical Homeopathy.

Tournier A, Roberts R (2015) Chemical dyes can detect presence of homeopathic high dilutions. London, UK: HRI Research Article.

Chikramane P, Suresh A, Bellare J, Kane S (2010) Extreme homeopathic dilutions retain starting materials: A nanoparticulate perspective. Homeopathy 99: 231-242. https://bit.ly/3rOg7TK

Cahill K, Bradley E, Meyer D, Custer P, Holck D, Marcet M, et al. (2020) Functional Indications for Upper Eyelid Ptosis and Blepharoplasty Surgery. Ophthalmology 118: 2510-2517. Link: https://bit.ly/3jgmyLI

MedicineNet (2020) Definition of Ptosis of The Eyelids, Adult. Link: https://bit.ly/3C3x7tY

Sciencedirect.com (2020) Ptosis (Eyelid) - An Overview | Sciencedirect Topics. Link: https://bit.ly/3yluLV9

Battu VK, Meyer DR, Wobig JL (1996) Improvement in Subjective Visual Function and Quality of Life Outcome Measures After Blepharoptosis Surgery. Am J Ophthalmol 121: 677-686. Link: https://bit.ly/3CaIZu9

Townsendletter.com (2020) Homeopathic Potency Selection Simplified (Feb/March 2010) Townsend Letter For Doctors & Patients. Link: https://bit.ly/37iCh7q

Wholehealthnow.com. (2020) Comparison of Centesimal and LM Potency - Hahnemann's Advanced Methods. [online] Link: https://bit.ly/3lqIhTN